CHEMOMAB THERAPEUTICS LTD (CMMB)
US16385C1045 - ADR
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | 1.39M | |||
| Cash Equivalents | 6.60M | 9.29M | 13.52M | 15.19M | 11.67M | |||
| Marketable Securities | 12.78M | 10.49M | 26.37M | 45.98M | 20.00K | |||
| Other Current Assets | 514.00K | 1.11M | 1.85M | 1.53M | 140.00K | |||
| Total Current Assets | 19.89M | 20.90M | 41.74M | 62.69M | 11.84M | |||
| Non-Current Assets | ||||||||
| PPE Net | 577.00K | 695.00K | 590.00K | 700.00K | 580.00K | |||
| Other Non-Current Assets | 428.00K | 559.00K | 730.00K | 960.00K | 60.00K | |||
| Total Non-Current Assets | 1.00M | 1.25M | 1.32M | 1.66M | 640.00K | |||
| TOTAL ASSETS | 20.90M | 22.15M | 43.06M | 64.35M | 12.48M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 3.96M | 4.32M | 5.06M | 1.31M | 1.22M | |||
| Accounts Payable | 386.00K | 516.00K | 1.69M | 1.34M | 90.00K | |||
| Total Current Liabilities | 4.35M | 4.84M | 6.75M | 2.65M | 1.32M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 230.00K | 316.00K | 90.00K | 240.00K | 360.00K | |||
| Total Non-Current Liabilities | 230.00K | 316.00K | 90.00K | 240.00K | 350.00K | |||
| TOTAL LIABILITIES | 4.58M | 5.15M | 6.84M | 2.89M | 1.67M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -99.66M | -88.68M | -63.82M | -36.17M | -23.70M | |||
| Additional Paid In Capital | 115.98M | 105.67M | 101.26M | 97.64M | 34.50M | |||
| Common Shares | 0.00 | 0.00 | 0.00 | 0.00 | N/A | |||
| Treasury Stock | N/A | 0.00 | -1.22M | N/A | N/A | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | 870.00K | |||
| Shares Outstanding | 20.28M | 763.89K | 781.92K | 766.86K | 31.19K | |||
| Tangible Book Value per Share | 0.04 | 1.20 | 2.49 | 4.31 | 18.62 | |||
| Total Shareholders' Equity | 16.32M | 17.00M | 36.22M | 61.47M | 10.80M | |||
| TOTAL LIABILITIES AND EQUITY | 20.90M | 22.15M | 43.06M | 64.35M | 12.48M | |||
| Statistics | ||||||||
| Current Ratio | 4.57 | 4.32 | 6.18 | 23.66 | 8.97 | |||
| Return On Assets (ROA) | -68.90% | -109.34% | -64.21% | -19.39% | -93.03% | |||
| Return On Equity (ROE) | -88.24% | -142.50% | -76.34% | -20.30% | -107.50% | |||
All data in USD , ROIC based on taxRate of 0.21